Sosialisasi Kegiatan Webinar: Kenali Bahaya Penyalahgunaan Obat Sedatif Sejak Dini
DOI:
https://doi.org/10.36312/nuras.v6i3.1242Keywords:
Public Health, Sedative Drugs, Knowledge Enhancement, Drug Abuse, Educational WebinarAbstract
Sedative drug abuse remains a public health issue that can lead to dependency, cognitive impairment, respiratory problems, and various adverse social consequences. Limited public knowledge particularly among university students regarding the safe use of sedative drugs is a factor that increases the risk of abuse. This activity aimed to raise participant knowledge and awareness regarding the dangers of sedative drug abuse from an early stage. An educational webinar conducted via Zoom served as the method, involving 20 participants comprising university students and the general public. The material was delivered through presentations, interactive discussions, and Q&A sessions. Evaluation was conducted using pre-test and post-test methods to measure participants' level of understanding following the webinar. Results showed that all participants completed the activity and submitted the post-test. Participants demonstrated a high level of knowledge after the webinar, with correct answer rates ranging from 70% to 100% across all indicators. The highest level of understanding was observed regarding examples of benzodiazepine drugs (100% correct answers), while the lowest was regarding the sedative class with the highest risk of dependency (70% correct answers). Overall, there was an increase in participant knowledge, with an average understanding level of 85%. Participants responded positively to the material and actively engaged in the discussion and Q&A sessions. The tangible impact of this activity was heightened participant awareness regarding the dangers of sedative drug abuse and the importance of using medication according to healthcare professionals' recommendations, thereby helping to prevent drug abuse among students and the general public.
Downloads
References
BPOM. (2020). Pedoman Penggunaan Obat yang Rasional. Jakarta: Badan Pengawas Obat dan Makanan Republik Indonesia.
Goodman, L. S., Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2018). Goodman & Gilman's the Pharmacological Basis of Therapeutics (13th ed.). New York: McGraw-Hill Education.
Katzung, B. G., Vanderah, T. W., & Trevor, A. J. (2021). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill Education.
Kementerian Kesehatan Republik Indonesia. (2021). Petunjuk Teknis Penggunaan Obat Psikotropika. Jakarta: Kementerian Kesehatan Republik Indonesia.
Lembke, A., Papac, J., & Humphreys, K. (2018). Our Other Prescription Drug Problem. New England Journal of Medicine, 378(8), 693–695. https://doi.org/10.1056/NEJMp1715050
Maust, D. T., Lin, L. A., & Blow, F. C. (2019). Benzodiazepine Use and Misuse Among Adults in the United States. Psychiatric Services, 70(2), 97–106. https://doi.org/10.1176/appi.ps.201800321
Rang, H. P., Ritter, J. M., Flower, R. J., Henderson, G., & Dale, M. M. (2019). Rang and Dale's Pharmacology (9th ed.). London: Elsevier.
Stahl, S. M. (2021). Stahl's Essential Psychopharmacology: Neuroscientific Basis And Practical Applications (5th ed.). Cambridge: Cambridge University Press.
UNODC. (2023). World Drug Report 2023. Vienna: United Nations Office on Drugs and Crime.
WHO. (2019). Guidelines for the Rational Use of Medicines. Geneva: World Health Organization.
Zolezzi, M., Alamri, M., Shaar, S., & Rainkie, D. (2018). Drug-Induced Cognitive Impairment: Effect of Sedative and Hypnotic Medications. Mental Health Clinician, 8(3), 121–127. https://doi.org/10.9740/mhc.2018.05.121
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Herman Widjaja, Aryanilo, Adylla Adawiyah Haryana, Junaida Pramesti, Mario Parningotan Hutapea, Susana Jelita Lestari Tandang, Pida Khaerunisa, Raditha Dellafanny, Fulgencia Maria Amelia De Jesus Soares, & Winda Novaliani

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

